Trulieve stock cuts debt as third quarter results near

Published on 10/08/2026 at 03:13 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Trulieve stock was last at USD 10.78 on October 7, 2026, as the company reduced debt to USD 225 million. Q2 revenue reached USD 270.952 million.

TRUL, US89790E1064, Illustration mit AI erstellt.

Trulieve Cannabis Corp. (ISIN US89790E1064) was last at USD 10.78 on the NYSE on October 7, 2026, up 1.22 percent from the prior close. The company had repaid mortgage notes before maturity, making balance-sheet leverage the central stock issue.

Debt falls before results

According to Trulieve on October 7, 2026, the company fully repaid mortgage notes secured by a cultivation site in Jefferson County, Florida, reducing outstanding debt to USD 225 million.

The repayment came ahead of maturity and was funded by cash generation, according to the company. Trulieve also linked the lower leverage to reduced annual interest expense and improved cash flow, while expansion in Georgia and Texas remains tied to regulatory approvals.

Q2 numbers show the tradeoff

Trulieve reported USD 270.952 million of Q2 2026 revenue, according to the Yahoo Finance transcript of the August 7, 2026 earnings call. Adjusted EBITDA was USD 98 million, equal to a 36 percent margin, while operating cash flow reached USD 53 million and free cash flow was USD 32 million.

The headline GAAP net loss was USD 406 million in Q2 2026, but the same transcript attributed USD 407 million to the Harvest deconsolidation and related equity investment. Excluding non-recurring items, adjusted net income was USD 20 million, or USD 0.11 per share, creating a sharper contrast between reported earnings and operating performance.

Analyst target stays above stock

The Globe and Mail reported on October 6, 2026 that Roth MKM analyst Bill Kirk reiterated a Buy rating and set a USD 19.00 price target. The report also cited Cantor Fitzgerald at Buy with a USD 15.00 target.

The published consensus was Strong Buy with an average price target of USD 17.81. Against the October 7, 2026 NYSE price of USD 10.78, that average target lies 65.2 percent above the stock price, making debt reduction and cash conversion important tests for the valuation.

Stock remains below yearly high

TRLV traded within a 52-week range of USD 4.62 to USD 13.28 as of October 7, 2026, with volume of 2,011,527 shares and market capitalization of USD 1.8 billion. The next scheduled checkpoint is the release of third-quarter 2026 results on November 5, 2026.